EANM’09 – CME Session VI
October 13, 2009, 11:30-13:00
Therapy Response Monitoring in Oncology
Moderator: A. Chiti (Milan)
- Know the general principles of therapy assessment in oncology.
- Understand the rationale which justifies the use of PET in evaluating response.
- Understand the technical and biological limitations of the technique.
The session is directed towards nuclear physicians experienced with PET/CT in oncology aimed to increase their knowledge in this application.
PET is increasingly used to monitor therapy efficacy, particularly since the widespread use of several new drugs arise a number of difficulties in monitoring treatment response with morphologic imaging. The high costs and possible side effects of chemotherapy and radiation therapy treatments, particularly when new drugs are employed, justify the use of more effective ways to monitor the treatment efficacy in oncology. Molecular imaging demonstrated to be effective in evaluating the response after and during the course of therapy. From a nuclear medicine point of view, knowledge of the oncology needs and of the technical aspects is mandatory in order to avoid critical errors.
Therapy Monitoring, Oncology, PET